Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Sep 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a new physical examination method can help identify movement problems in the joints of adults, particularly those who have had a stroke or a transient ischemic attack (TIA), which is a temporary episode of stroke-like symptoms. The researchers want to find out if different healthcare providers can reliably detect these movement issues using a systematic approach, and whether the severity of these problems relates to the recovery outcomes of stroke survivors.
To participate in the study, you need to be an adult aged 18 or older who has been admitted to the hospital for an ischemic stroke or TIA. You should be stable for at least 24 hours and able to sit and lie down with minimal assistance. Participants will undergo a series of physical exams by independent providers, who will not know each other's assessments or the patients' details. If you join the study and have had a stroke, you'll also complete a survey about your quality of life three months after your hospital stay. This trial is currently recruiting participants, and it aims to improve understanding of how movement issues affect recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults ≥18 years
- Admission diagnosis:
- • ischemic stroke OR
- • transient ischemic attack (TIA). A prior history of TIA but without stroke may be enrolled.
- • Neurologic stability or lack of significant deterioration (i.e. ∆ NIHSS\<4) for at least 24 hours (defined by clinical documentation and/or communication with provider team(s)) in stroke subjects
- • Able to sit upright, lie supine, and when able lateral recumbent left/right positions with assist independently or with minimal person assist
- • Anticipated length of stay greater \> or = 2 days for ischemic stroke. TIA patients average length of stay is \< 2 days, and can be enrolled in the study.
- Exclusion Criteria:
- • Acute skeletal fracture or known dislocation; history of pathologic (osteoporotic or neoplastic) skeletal fracture of thoracic cage, hip/pelvis/sacrum, or vertebral column
- • Prior history of ICH, ischemic stroke, confirmed by imaging and/or clinical evaluation. Patients with imaging showing "chronic stroke" who have never received a diagnosis of stroke and/or have not been previously symptomatic may still be enrolled, based on the Investigator's clinical judgement.
- • Spinal column support brace (e.g. cervical collar)
- • Anticipated neurosurgical intervention during hospitalization: decompressive hemicraniectomy, hematoma evacuation (defined by clinical documentation and/or communication with provider team(s))
- • Current endotracheal intubation (\*note: extubated patients can be evaluated for eligibility)
- • History of spinal cord injury with residual neuromuscular or sensory disability
- • History of recent trauma within the past 30 days
- • Known ligament, musculotendinous, or bone lesion
- • Clinical condition that would interfere with execution of movement or palpatory diagnostic testing, e.g. chronic pain
- • History of spinal surgery
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Alan Yee, D.O.
Principal Investigator
University of California, Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported